Carla J. Greenbaum MD

Carla Greenbaum MD is Director of the Diabetes Program at Benaroya Research Institute in Seattle WA. She has expertise in clinical trial design and implementation and evaluation of biomarkers for disease course and response to therapy. For more than 25 years, Dr. Greenbaum has conducted studies evaluating beta cell function and other physiologic and immune changes that occur during the progression of type 1 diabetes. She currently serves as Chair of Diabetes TrialNet, an NIH-sponsored international multi-center clinical trial network aiming to bring disease-modifying therapy to clinical use. Dr. Greenbaum received her medical degree at Brown University and underwent endocrinology fellowship training at University of Washington.